Compounds > n-acetyl-s-farnesylcysteine
Page last updated: 2024-09-03

n-acetyl-s-farnesylcysteine and adenosine 5'-o-(3-thiotriphosphate)

n-acetyl-s-farnesylcysteine has been researched along with adenosine 5'-o-(3-thiotriphosphate) in 1 studies

Compound Research Comparison

Studies
(n-acetyl-s-farnesylcysteine)		Trials
(n-acetyl-s-farnesylcysteine)		Recent Studies (post-2010)
(n-acetyl-s-farnesylcysteine)		Studies
(adenosine 5'-o-(3-thiotriphosphate))		Trials
(adenosine 5'-o-(3-thiotriphosphate))		Recent Studies (post-2010) (adenosine 5'-o-(3-thiotriphosphate))
42069750120

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Adhami, K; Ding, W; Gordon, JS; Granstein, RD; Lee, J; Levin, L; Moquete, R; Perez, E; Schierl, M; Stock, MB; Stohl, LL; Wong, J; Zhou, XK1

Other Studies

1 other study(ies) available for n-acetyl-s-farnesylcysteine and adenosine 5'-o-(3-thiotriphosphate)

ArticleYear
N-acetyl-S-farnesyl-l-cysteine suppresses chemokine production by human dermal microvascular endothelial cells.
    Experimental dermatology, 2012, Volume: 21, Issue:9

    Topics: Acetylcysteine; Adenosine Triphosphate; Cell Survival; Cells, Cultured; Chemokine CCL2; Chemokine CXCL1; Cyclic AMP; Endothelial Cells; Humans; Interleukin-8; Microvessels; RNA, Messenger; Skin; Tumor Necrosis Factor-alpha

2012